Works by Satouchi, Miyako


Results: 43
    1
    2

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    3
    4

    Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
    By:
    • Katsuyuki Kiura;
    • Fumio Imamura;
    • Hiroshi Kagamu;
    • Shingo Matsumoto;
    • Toyoaki Hida;
    • Kazuhiko Nakagawa;
    • Miyako Satouchi;
    • Isamu Okamoto;
    • Mitsuhiro Takenoyama;
    • Yasuhito Fujisaka;
    • Takayasu Kurata;
    • Masayuki Ito;
    • Kota Tokushige;
    • Hatano, Ben;
    • Makoto Nishio
    Publication type:
    Article
    5
    6
    7
    8

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    9
    10

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    11

    First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 695, doi. 10.1007/s10147-022-02120-0
    By:
    • John, Thomas;
    • Sakai, Hiroshi;
    • Ikeda, Satoshi;
    • Cheng, Ying;
    • Kasahara, Kazuo;
    • Sato, Yuki;
    • Nakahara, Yoshiro;
    • Takeda, Masayuki;
    • Kaneda, Hiroyasu;
    • Zhang, Helong;
    • Maemondo, Makoto;
    • Minato, Koichi;
    • Hisada, Takeshi;
    • Misumi, Yuki;
    • Satouchi, Miyako;
    • Hotta, Katsuyuki;
    • Li, Ang;
    • Oukessou, Abderrahim;
    • Lu, Shun
    Publication type:
    Article
    12

    Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

    Published in:
    Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
    By:
    • Tachihara, Motoko;
    • Tsujino, Kayoko;
    • Ishihara, Takeaki;
    • Hayashi, Hidetoshi;
    • Sato, Yuki;
    • Kurata, Takayasu;
    • Sugawara, Shunichi;
    • Okamoto, Isamu;
    • Teraoka, Shunsuke;
    • Azuma, Koichi;
    • Daga, Haruko;
    • Yamaguchi, Masafumi;
    • Kodaira, Takeshi;
    • Satouchi, Miyako;
    • Shimokawa, Mototsugu;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2275, doi. 10.1002/cncr.28048
    By:
    • Urata, Yoshiko;
    • Okamoto, Isamu;
    • Takeda, Masayuki;
    • Hattori, Yoshihiro;
    • Okuno, Keiko;
    • Shimada, Temiko;
    • Kurata, Takayasu;
    • Kaneda, Hiroyasu;
    • Miyazaki, Masaki;
    • Terashima, Masaaki;
    • Tanaka, Kaoru;
    • Morita, Satoshi;
    • Nakagawa, Kazuhiko;
    • Negoro, Shunichi;
    • Satouchi, Miyako
    Publication type:
    Article
    20

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    21

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    22

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    23

    Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576
    By:
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Satouchi, Miyako;
    • Goto, Yasushi;
    • Niho, Seiji;
    • Nogami, Naoyuki;
    • Hida, Toyoaki;
    • Takahashi, Toshiaki;
    • Sakakibara‐Konishi, Jun;
    • Morise, Masahiro;
    • Nagasawa, Takashi;
    • Suzuki, Mie;
    • Ohkura, Masayuki;
    • Fukuhara, Kei;
    • Thurm, Holger;
    • Peltz, Gerson;
    • Nishio, Makoto
    Publication type:
    Article
    24
    25

    KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 3, p. 1012, doi. 10.1111/cas.13932
    By:
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Yoshioka, Hiroshige;
    • Nakagawa, Kazuhiko;
    • Fukuhara, Tatsuro;
    • Yamada, Kazuhiko;
    • Ichiki, Masao;
    • Tanaka, Hiroshi;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Han, Shi Rong;
    • Noguchi, Kazuo;
    • Shimamoto, Takashi;
    • Kato, Terufumi
    Publication type:
    Article
    26

    ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651
    By:
    • Azuma, Koichi;
    • Nishio, Makoto;
    • Hayashi, Hidetoshi;
    • Kiura, Katsuyuki;
    • Satouchi, Miyako;
    • Sugawara, Shunichi;
    • Hida, Toyoaki;
    • Iwamoto, Yasuo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Ikeda, Satoshi;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Asahina, Seitaro;
    • Komatsu, Kanji;
    • Morita, Satoshi;
    • Fukuoka, Masahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    27
    28

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    29
    30
    31
    32

    Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).

    Published in:
    2017
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Hattori, Yoshihiro;
    • Tanaka, Kosuke;
    • Fujita, Shiro;
    • Kotani, Yoshikazu;
    • Nishimura, Takashi;
    • Imamura, Fumio;
    • Yokota, Soichiro;
    • Satouchi, Miyako;
    • Monden, Kazuya;
    • Otsuka, Kojiro;
    • Nishiyama, Akihiro;
    • Tsubouchi, Kazuya;
    • Kaneda, Toshihiko;
    • Yoshioka, Hiroshige;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    journal article
    33
    34
    35

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    36

    Multiplex gene‐panel testing for lung cancer patients.

    Published in:
    Pathology International, 2020, v. 70, n. 12, p. 921, doi. 10.1111/pin.13023
    By:
    • Yatabe, Yasushi;
    • Sunami, Kuniko;
    • Goto, Koichi;
    • Nishio, Kazuto;
    • Aragane, Naoko;
    • Ikeda, Sadakatsu;
    • Inoue, Akira;
    • Kinoshita, Ichiro;
    • Kimura, Hideharu;
    • Sakamoto, Tomohiro;
    • Satouchi, Miyako;
    • Shimizu, Junichi;
    • Tsuta, Koji;
    • Toyooka, Shinichi;
    • Nishino, Kazumi;
    • Hatanaka, Yutaka;
    • Matsumoto, Shingo;
    • Mikubo, Masashi;
    • Yokose, Tomoyuki;
    • Dosaka‐Akita, Hirotoshi
    Publication type:
    Article
    37
    38
    39
    40

    Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 6, p. 475, doi. 10.1634/theoncologist.2019-0746
    By:
    • Tsuchiya‐Kawano, Yuko;
    • Sasaki, Tomonari;
    • Yamaguchi, Hiroyuki;
    • Hirano, Katsuya;
    • Horiike, Atsushi;
    • Satouchi, Miyako;
    • Hosokawa, Shinobu;
    • Morinaga, Ryotaro;
    • Komiya, Kazutoshi;
    • Inoue, Koji;
    • Fujita, Yuka;
    • Toyozawa, Ryo;
    • Kimura, Tomoki;
    • Takahashi, Kosuke;
    • Nishikawa, Kazuo;
    • Kishimoto, Junji;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    Article
    41

    KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 3, p. 261, doi. 10.1007/s10637-024-01422-6
    By:
    • Yamamoto, Noboru;
    • Satouchi, Miyako;
    • Doi, Toshihiko;
    • Fujiwara, Yutaka;
    • Yanagitani, Noriko;
    • Kawa, Yoshitaka;
    • Yoh, Kiyotaka;
    • Leopold, Lance;
    • Munteanu, Mihaela;
    • Sawada, Takashi;
    • Han, Shirong;
    • Noguchi, Kazuo;
    • Nishio, Makoto
    Publication type:
    Article
    42
    43